Kila Murphey
Adult Health · Orlando, FLNPI 1487131173
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 73.7% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $3,666, more than ten times the $166 reported in 2021. Among adult health clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $46.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$4K
- AbbVie$489
- Johnson & Johnson$262
- Otsuka America Pharmaceutical, Inc.$209
- Indivior Inc.$126
- Alkermes, Inc.$117
- plus $255 from 8 others
What the payments were for
- Travel & lodging$2,95653%
- Food & beverage$2,43244%
- Education$1683%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 36 | $4,097 |
| AbbVie | 28 | $489 |
| Johnson & Johnson | 17 | $262 |
| Otsuka America Pharmaceutical, Inc. | 12 | $209 |
| Indivior Inc. | 6 | $126 |
| Alkermes, Inc. | 6 | $117 |
| Abbott | 5 | $111 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Lilly USA, LLC | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $15 |
| Tris Pharma Inc | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$2,390
How this compares
$5,555 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 37 | $110,839 |
| Abilify MaintenaAripiprazole | 12 | $32,105 |
| Aripiprazole | 52 | $4,713 |
| Lurasidone Hcl | 13 | $3,571 |
| Paliperidone ErPaliperidone | 38 | $3,569 |
| Olanzapine | 53 | $3,385 |
| Oxcarbazepine | 50 | $2,252 |
| Haloperidol | 75 | $2,124 |
| Fluphenazine Hcl | 15 | $1,967 |
| Ziprasidone Hcl | 22 | $1,905 |
| Benztropine Mesylate | 132 | $1,397 |
| Hydroxyzine Hcl | 60 | $1,372 |
| Buspirone Hcl | 77 | $1,345 |
| Quetiapine Fumarate | 66 | $1,076 |
| Risperidone | 105 | $933 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $262 | $110,83937 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $209 | $32,10512 claims |
| Lilly USA, LLCOlanzapine | $24 | $3,38553 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.
Other adult health in Orlando
- Sita SwamyOrlando$49K
- Andreina NeallOrlando$16K
- Jessica SettineriOrlando$14K
- Kristen KessingerOrlando$13K
- Angelo LewisOrlando$12K
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.